RefleXion Medical
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$105M
RefleXion Medical develops and commercializes SCINTIX therapy, a novel treatment for all stages of indicated solid tumor cancers, including metastatic disease, delivered via the RefleXion X1 platform.
Focus Areas
Therapeutic Oncology
Solid Tumor Cancer Treatment
SCINTIX Therapy
Breakthrough Device Designation
FDA Marketing Authorization
RefleXion X1 Platform
Investors
